MedPath

T-proBNP Testing in Patients Presenting to the Emergency Department With Acute Dyspnea: Evaluation of Effects on Treatment, Hospitalisation Rate and Costs

Completed
Conditions
dyspnea (dyspnoe)
amino-terminal pro B-type natriuretic peptide (amino-terminaal pro B-type natriuretisch peptide)
costs (kosten)
cost-effectiveness (kosteneffectiviteit)
Registration Number
NL-OMON24573
Lead Sponsor
Erasmus MCDepartment of Internal Medicine's Gravendijkwal 2303015 CE Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
477
Inclusion Criteria

1. Age 18 years or older;
2. Acute dyspnea as the most prominent complaint

Exclusion Criteria

1. Acute dyspnea due to a trauma;
2. Acute dyspnea due to cardiogenic shock;
3. Renal failure requiring dialysis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Time to discharge; <br>2. Cost of treatment
Secondary Outcome Measures
NameTimeMethod
1. Duration of stay at the ED; <br>2. Proportion of patients admitted to the hospital; <br>3. Proportion of patients admitted to an intensive or coronary care unit; <br>4. Specialist consultations; <br>5. Medical treatment; <br>6. Diagnostic investigations
© Copyright 2025. All Rights Reserved by MedPath